Sweden accepted a Levaxin price increase to protect supply continuity, showing how HTA and reimbursement decisions can reflect access risk.
https://www.mattheneus.com/editorial/tlv-levaxin-price-increase-supply-continuity-hypothyroidism-2026-06-15 #HTA #RegulatoryAffairs #Pharma
Swedish agency grants Levaxin price increase to protect supply continuity
The Swedish Dental and Pharmaceutical Benefits Agency approved higher reimbursed prices for three Levaxin pack lines after assessing clinical importance, substitutability, and risk of benefit-system exit.
AbangeLabs Editorial